
RSSDI and Sanofi’s Type 1 Diabetes Social Impact program delivers positive outcomes for more than 1300 children
27th September, 2023: The Research Society for the Study of Diabetes in India (RSSDI) and Sanofi have been engaged in a three-year-old programme. This programme has begun showing significant impact on the lives of children who have been affected by Type 1 Diabetes Mellitus (T1D). As part of the People-to-People Health Foundation (PPHF) more than 1300 young patients young TID affected patients nationwide have been enrolled out of which 69 patients are from Maharashtra. This program is imparting better education on TID management to the 1300 children. The program’s intervention over the last 9 months spanning September 2022 to June 2023 has reduced the number of children experiencing hypoglycaemia (1 to 4 times a week) by 46% as compared to








